Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 5
2015 2
2016 3
2017 2
2018 1
2019 2
2020 2
2021 5
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Estimated Prevalence, Tumor Spectrum, and Neurofibromatosis Type 1-Like Phenotype of CDKN2A-Related Melanoma-Astrocytoma Syndrome.
Sargen MR, Kim J, Potjer TP, Velthuizen ME, Martir-Negron AE, Odia Y, Helgadottir H, Hatton JN, Haley JS, Thone G, Widemann BC, Gross AM, Yohe ME, Kaplan RN, Shern JF, Sundby RT, Astiazaran-Symonds E, Yang XR, Carey DJ, Tucker MA, Stewart DR, Goldstein AM. Sargen MR, et al. Among authors: velthuizen me. JAMA Dermatol. 2023 Oct 1;159(10):1112-1118. doi: 10.1001/jamadermatol.2023.2621. JAMA Dermatol. 2023. PMID: 37585199
Serum AMH levels in healthy women from BRCA1/2 mutated families: are they reduced?
van Tilborg TC, Derks-Smeets IA, Bos AM, Oosterwijk JC, van Golde RJ, de Die-Smulders CE, van der Kolk LE, van Zelst-Stams WA, Velthuizen ME, Hoek A, Eijkemans MJ, Laven JS, Ausems MG, Broekmans FJ. van Tilborg TC, et al. Among authors: velthuizen me. Hum Reprod. 2016 Nov;31(11):2651-2659. doi: 10.1093/humrep/dew242. Epub 2016 Oct 5. Hum Reprod. 2016. PMID: 27907901
Mainstream germline genetic testing for patients with epithelial ovarian cancer leads to higher testing rates and a reduction in genetics-related healthcare costs from a healthcare payer perspective.
Bokkers K, Frederix GWJ, Velthuizen ME, van der Aa M, Gerestein CG, van Dorst EBL, Lange JG, Louwers JA, Koole W, Zweemer RP, Ausems MGEM. Bokkers K, et al. Among authors: velthuizen me. Gynecol Oncol. 2022 Oct;167(1):115-122. doi: 10.1016/j.ygyno.2022.08.011. Epub 2022 Aug 26. Gynecol Oncol. 2022. PMID: 36031452 Free article.
Patients' experiences with pre-test genetic counseling provided by breast cancer healthcare professionals: Results from a large prospective multicenter study.
Bokkers K, Bleiker EMA, Velthuizen ME, Koelemij R, Burgmans JPJ, Klinkenbijl JH, Schouten van der Velden AP, Vermulst N, Huizinga BF, Witkamp AJ, Frakking T, Brohet RM, Aalfs CM, Koole W, Schoenmaeckers EJP, Ausems MGEM. Bokkers K, et al. Among authors: velthuizen me. Breast. 2023 Jun;69:349-357. doi: 10.1016/j.breast.2023.03.017. Epub 2023 Mar 29. Breast. 2023. PMID: 37018966 Free PMC article.
TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort.
Bakhuizen JJ, Hogervorst FB, Velthuizen ME, Ruijs MW, van Engelen K, van Os TA, Gille JJ, Collée M, van den Ouweland AM, van Asperen CJ, Kets CM, Mensenkamp AR, Leter EM, Blok MJ, de Jong MM, Ausems MG. Bakhuizen JJ, et al. Among authors: velthuizen me. Fam Cancer. 2019 Apr;18(2):273-280. doi: 10.1007/s10689-018-00118-0. Fam Cancer. 2019. PMID: 30607672
Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testing.
Bokkers K, Bleiker EMA, Hoogendam JP, Velthuizen ME, Schreuder HWR, Gerestein CG, Lange JG, Louwers JA, Koudijs MJ, Ausems MGEM, Zweemer RP. Bokkers K, et al. Among authors: velthuizen me. Hered Cancer Clin Pract. 2022 Sep 8;20(1):33. doi: 10.1186/s13053-022-00238-w. Hered Cancer Clin Pract. 2022. PMID: 36076240 Free PMC article.
24 results